Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for […]
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for […]
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of […]
– Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; […]
GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA […]
RAPID CITY, S.D., May 13, 2024 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced the pricing of a […]
BELGRADE, Mont., May 13, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: […]
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial […]
– On Track to Provide Topline Data from the Ongoing Pivotal Clinical Trial with Oxylanthanum Carbonate (OLC) in Q2 2024 […]
CINCINNATI, May 13, 2024 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management […]
BARTLETT, Tenn., May 13, 2024 (GLOBE NEWSWIRE) — SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecom […]